Catalyst Event
Joinn Laboratories (China) Co Ltd (6127) · Other
From Akros SCHK HK-Global Genomics Index (ASHGGENM)
6/4/2026, 12:00:00 AM
Announced the establishment of a Strategic Development Committee on 2026-06-04 to enhance oversight of major investments and long-term planning; low importance as internal governance changes typically have minimal price impact of 1-5% scheduled.
Korean Translation
2026년 6월 4일 주요 투자 및 장기 계획 감독 강화를 위한 전략 개발 위원회 설립을 발표함. 내부 거버넌스 변경은 통상적으로 1-5% 수준의 미미한 주가 영향을 미칠 것으로 예정됨.
Related Recent Events
Pacific Biosciences of California Inc (PACB) · Earnings Release
Q2 2026 earnings release is scheduled.
8/6/2026, 12:00:00 AM
Pharmaron Beijing Co Ltd (3759) · Other
The ex-dividend date for the RMB 0.20 per share final dividend on July 7, 2026, with payment on August 7, 2026; market reaction is estimated at Low as the payout is within expected ranges scheduled.
7/7/2026, 12:00:00 AM
Jinxin Fertility Group Limited (1951) · Other
Ex-dividend date on 2026-06-29 for the 2025 final dividend of HK$0.0418 per share; Low importance justified by it being a standard technical adjustment scheduled
6/29/2026, 12:00:00 AM
Hansoh Pharmaceutical Group Company Limited (3692) · Other
Annual General Meeting on June 26, 2026, to approve 2025 results and dividends. Analysts estimate a 1-5% price impact for this routine corporate event scheduled.
6/26/2026, 12:00:00 AM
Jinxin Fertility Group Limited (1951) · Other
Annual General Meeting on 2026-06-25 to vote on 2025 financial statements and a HK$0.0418 dividend; Low importance justified by the routine nature of the meeting scheduled
6/25/2026, 12:00:00 AM
Biocytogen Pharmaceuticals (Beijing) Co Ltd (2315) · Other
An extraordinary general meeting is scheduled on 2026-06-25 to vote on a new executive remuneration system and a 10% H-share repurchase mandate; 1% price impact expected.
6/25/2026, 12:00:00 AM